DOP21: Histo-endoscopic remission (HEMR) Predicts Future Relapse in Patients with Ulcerative Colitis and is Associated with Lower Colectomy RiskECCO'24 Stockholm 2024
DOP22: Predictive biomarkers of therapeutic response in Inflammatory Bowel Disease: a step towards personalized medicine.ECCO'24 Stockholm 2024
DOP23: The role of histology for the prediction of clinical relapse in Crohn’s Disease: A substudy of the STORI cohortECCO'24 Stockholm 2024
DOP25: Antibodies against Neutrophil Extracellular Traps (ANETAs) are associated with more severe disease course in Ulcerative ColitisECCO'24 Stockholm 2024
DOP26: Metagenomic and metabolomic profiles in IBD: understanding microbial and metabolic shifts from a large deeply phenotyped cohortECCO'24 Stockholm 2024
DOP27: Systemic antibody responses against gut microbiota flagellins implicate shared and divergent immune reactivity in Crohn's Disease and chronic fatigue syndromeECCO'24 Stockholm 2024
DOP28: Yield of surveillance colonoscopy in patients with Primary Sclerosing CholangitisECCO'24 Stockholm 2024
DOP29: Capsule endoscopy-guided proactive treatment versus standard treatment of patients with quiescent Crohn’s Disease: The CURE-CD randomized controlled trialECCO'24 Stockholm 2024
DOP30: Cross-ethnic microbiome analyses identify shared and specific signals for Northern Indian IBD patientsECCO'24 Stockholm 2024
DOP31: Gene correlation network analyses reveal transcript modules and pathogenic mechanisms associated with resistance and response to ustekinumab therapy in Ulcerative ColitisECCO'24 Stockholm 2024
DOP32: CD226+TIGITneg expression identifies pathogenic inflammatory CD4+ memory T cells in severe Crohn’s Disease patients, opening up opportunities for patient-tailored treatment strategies.ECCO'24 Stockholm 2024
DOP33: Distinct perturbances in metabolic pathways associate with disease progression in patients with Inflammatory Bowel DiseaseECCO'24 Stockholm 2024
DOP34: Deciphering immune-epithelial interactions in health and in Inflammatory Bowel DiseaseECCO'24 Stockholm 2024
DOP35: Spatial transcriptomics reveals cellular niches associated with histological inflammation in postoperative Crohn’s DiseaseECCO'24 Stockholm 2024
DOP37: Noninvasive assessment of gut function using transcriptional recording sentinel cellsECCO'24 Stockholm 2024
DOP38: A rare KRT17+ population emerges from the epithelium in the inflamed intestinal mucosa of patients with Ulcerative ColitisECCO'24 Stockholm 2024
DOP39: Constructing butyrate-producing yeast as a cell-dependent treatment option for Inflammatory Bowel DiseaseECCO'24 Stockholm 2024